The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

HIV-AIDS Testing-Global Market Insights and Sales Trends 2024

HIV-AIDS Testing-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1863549

No of Pages : 124

Ask Your Query

Synopsis

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.

HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.

The global HIV-AIDS Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV-AIDS Testing in various end use industries. The expanding demands from the Hospitals, Private Diagnostics Laboratories, Academic and Research Institutes and Others, are propelling HIV-AIDS Testing market. Kits and Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for HIV-AIDS Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the HIV-AIDS Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV-AIDS Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global HIV-AIDS Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global HIV-AIDS Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV-AIDS Testing sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of HIV-AIDS Testing covered in this report include Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix and DiaSorin, etc.

The global HIV-AIDS Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Lonza
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio

Global HIV-AIDS Testing market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global HIV-AIDS Testing market, Segment by Type:

  • Kits and Reagents
  • Instruments
  • Others

Global HIV-AIDS Testing market, by Application:

  • Hospitals
  • Private Diagnostics Laboratories
  • Academic and Research Institutes
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV-AIDS Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of HIV-AIDS Testing
1.1 HIV-AIDS Testing Market Overview
1.1.1 HIV-AIDS Testing Product Scope
1.1.2 HIV-AIDS Testing Market Status and Outlook
1.2 Global HIV-AIDS Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HIV-AIDS Testing Market Size by Region (2018-2029)
1.4 Global HIV-AIDS Testing Historic Market Size by Region (2018-2023)
1.5 Global HIV-AIDS Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HIV-AIDS Testing Market Size (2018-2029)
1.6.1 North America HIV-AIDS Testing Market Size (2018-2029)
1.6.2 Europe HIV-AIDS Testing Market Size (2018-2029)
1.6.3 Asia-Pacific HIV-AIDS Testing Market Size (2018-2029)
1.6.4 Latin America HIV-AIDS Testing Market Size (2018-2029)
1.6.5 Middle East & Africa HIV-AIDS Testing Market Size (2018-2029)
2 HIV-AIDS Testing Market by Type
2.1 Introduction
2.1.1 Kits and Reagents
2.1.2 Instruments
2.1.3 Others
2.2 Global HIV-AIDS Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HIV-AIDS Testing Historic Market Size by Type (2018-2023)
2.2.2 Global HIV-AIDS Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HIV-AIDS Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HIV-AIDS Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HIV-AIDS Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HIV-AIDS Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HIV-AIDS Testing Revenue Breakdown by Type (2018-2029)
3 HIV-AIDS Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Private Diagnostics Laboratories
3.1.3 Academic and Research Institutes
3.1.4 Others
3.2 Global HIV-AIDS Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HIV-AIDS Testing Historic Market Size by Application (2018-2023)
3.2.2 Global HIV-AIDS Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HIV-AIDS Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HIV-AIDS Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HIV-AIDS Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HIV-AIDS Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HIV-AIDS Testing Revenue Breakdown by Application (2018-2029)
4 HIV-AIDS Testing Competition Analysis by Players
4.1 Global HIV-AIDS Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2022)
4.3 Date of Key Players Enter into HIV-AIDS Testing Market
4.4 Global Top Players HIV-AIDS Testing Headquarters and Area Served
4.5 Key Players HIV-AIDS Testing Product Solution and Service
4.6 Competitive Status
4.6.1 HIV-AIDS Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott HIV-AIDS Testing Products, Services and Solutions
5.1.4 Abbott HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Affymetrix
5.2.1 Affymetrix Profile
5.2.2 Affymetrix Main Business
5.2.3 Affymetrix HIV-AIDS Testing Products, Services and Solutions
5.2.4 Affymetrix HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Affymetrix Recent Developments
5.3 Beckman Coulter/Danaher
5.3.1 Beckman Coulter/Danaher Profile
5.3.2 Beckman Coulter/Danaher Main Business
5.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Products, Services and Solutions
5.3.4 Beckman Coulter/Danaher HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Becton Dickinson Recent Developments
5.4 Becton Dickinson
5.4.1 Becton Dickinson Profile
5.4.2 Becton Dickinson Main Business
5.4.3 Becton Dickinson HIV-AIDS Testing Products, Services and Solutions
5.4.4 Becton Dickinson HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Becton Dickinson Recent Developments
5.5 bioMerieux
5.5.1 bioMerieux Profile
5.5.2 bioMerieux Main Business
5.5.3 bioMerieux HIV-AIDS Testing Products, Services and Solutions
5.5.4 bioMerieux HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.5.5 bioMerieux Recent Developments
5.6 Bio-Rad
5.6.1 Bio-Rad Profile
5.6.2 Bio-Rad Main Business
5.6.3 Bio-Rad HIV-AIDS Testing Products, Services and Solutions
5.6.4 Bio-Rad HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Recent Developments
5.7 Cepheid
5.7.1 Cepheid Profile
5.7.2 Cepheid Main Business
5.7.3 Cepheid HIV-AIDS Testing Products, Services and Solutions
5.7.4 Cepheid HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Cepheid Recent Developments
5.8 Diamedix
5.8.1 Diamedix Profile
5.8.2 Diamedix Main Business
5.8.3 Diamedix HIV-AIDS Testing Products, Services and Solutions
5.8.4 Diamedix HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Diamedix Recent Developments
5.9 DiaSorin
5.9.1 DiaSorin Profile
5.9.2 DiaSorin Main Business
5.9.3 DiaSorin HIV-AIDS Testing Products, Services and Solutions
5.9.4 DiaSorin HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.9.5 DiaSorin Recent Developments
5.10 Eiken Chemical
5.10.1 Eiken Chemical Profile
5.10.2 Eiken Chemical Main Business
5.10.3 Eiken Chemical HIV-AIDS Testing Products, Services and Solutions
5.10.4 Eiken Chemical HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Eiken Chemical Recent Developments
5.11 Elitech Group
5.11.1 Elitech Group Profile
5.11.2 Elitech Group Main Business
5.11.3 Elitech Group HIV-AIDS Testing Products, Services and Solutions
5.11.4 Elitech Group HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Elitech Group Recent Developments
5.12 Enzo Biochem
5.12.1 Enzo Biochem Profile
5.12.2 Enzo Biochem Main Business
5.12.3 Enzo Biochem HIV-AIDS Testing Products, Services and Solutions
5.12.4 Enzo Biochem HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Enzo Biochem Recent Developments
5.13 Fujirebio
5.13.1 Fujirebio Profile
5.13.2 Fujirebio Main Business
5.13.3 Fujirebio HIV-AIDS Testing Products, Services and Solutions
5.13.4 Fujirebio HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Fujirebio Recent Developments
5.14 Lonza
5.14.1 Lonza Profile
5.14.2 Lonza Main Business
5.14.3 Lonza HIV-AIDS Testing Products, Services and Solutions
5.14.4 Lonza HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Lonza Recent Developments
5.15 Roche
5.15.1 Roche Profile
5.15.2 Roche Main Business
5.15.3 Roche HIV-AIDS Testing Products, Services and Solutions
5.15.4 Roche HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Roche Recent Developments
5.16 Scienion
5.16.1 Scienion Profile
5.16.2 Scienion Main Business
5.16.3 Scienion HIV-AIDS Testing Products, Services and Solutions
5.16.4 Scienion HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Scienion Recent Developments
5.17 Sequenom
5.17.1 Sequenom Profile
5.17.2 Sequenom Main Business
5.17.3 Sequenom HIV-AIDS Testing Products, Services and Solutions
5.17.4 Sequenom HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Sequenom Recent Developments
5.18 SeraCare
5.18.1 SeraCare Profile
5.18.2 SeraCare Main Business
5.18.3 SeraCare HIV-AIDS Testing Products, Services and Solutions
5.18.4 SeraCare HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.18.5 SeraCare Recent Developments
5.19 Siemens
5.19.1 Siemens Profile
5.19.2 Siemens Main Business
5.19.3 Siemens HIV-AIDS Testing Products, Services and Solutions
5.19.4 Siemens HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.19.5 Siemens Recent Developments
5.20 Takara Bio
5.20.1 Takara Bio Profile
5.20.2 Takara Bio Main Business
5.20.3 Takara Bio HIV-AIDS Testing Products, Services and Solutions
5.20.4 Takara Bio HIV-AIDS Testing Revenue (US$ Million) & (2018-2023)
5.20.5 Takara Bio Recent Developments
6 North America
6.1 North America HIV-AIDS Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HIV-AIDS Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HIV-AIDS Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HIV-AIDS Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HIV-AIDS Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HIV-AIDS Testing Market Dynamics
11.1 HIV-AIDS Testing Industry Trends
11.2 HIV-AIDS Testing Market Drivers
11.3 HIV-AIDS Testing Market Challenges
11.4 HIV-AIDS Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock